Loading clinical trials...

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT01097629

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)

This is a multicenter study to test the hypothesis that suvorexant (MK-4305) is superior to placebo in improving insomnia as measured by change from baseline in: subjective total sleep time and time t...

Lead sponsor: Merck Sharp & Dohme LLC•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia

NCT06996171 · Primary Insomnia

Not Yet RecruitingNA

Brisk Walking Training Compared with Cognitive Behavioral Therapy for the Treatment of Chronic Primary Insomnia in People Aged 60 Years or Above: a Randomized, Partially Blinded, Non-inferiority Trial

NCT06850272 · Primary Insomnia

COMPLETED

A High Density EEG Comparison of Sleep Patterns in Insomnia

NCT01960452 · Primary Insomnia

COMPLETEDPhase 2

Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs

NCT00816673 · Primary Insomnia

COMPLETEDNA

Effects of Regular Practice of Yoga on Subjective and Objective Sleep Quality in Primary Insomnia

NCT03314441 · Primary Insomnia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 28, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment1,020

Start dateMay 2010

Last updatedAug 28, 2019

Condition

Primary Insomnia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2019Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions